ArticleTherapeutic advances in medical oncology2020

Co-infusion of high-dose haploidentical donor cells and CD19-targeted CART cells achieves complete remission, successful donor engraftment and significant CART amplification in advanced ALL.

Changlin Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.